Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases

Journal of Pathology

Volumn 226, Issue 5, 2012, Pages 756-763

  Naidoo, Kalnisha ^a   Jones, Richard ^b   Dmitrovic, Branko ^c   Wijesuriya, Nilukshi ^d   Kocher, Hemant ^a   Hart, Ian R ^a   Crnogorac Jurcevic, Tatjana ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b MS BIOWORKS   (United States)

^c UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Ffpe proteomics; Laser capture microdissection; Lymphatic metastasis; PDAC

Indexed keywords

ALPHA CATENIN; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; BETA CATENIN; BETA1 INTEGRIN; BETA4 INTEGRIN; CATENIN; CATHEPSIN B; CATHEPSIN G; CATHEPSIN X; CD51 ANTIGEN; DETA CATENIN; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; IQGAP2 PROTEIN; MOESIN; PROTEIN S 100; PROTEIN S100P; PROTEOME; STRATIFIN; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CYTOPLASM; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LYMPH NODE METASTASIS; MULTIDIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY; PANCREAS ADENOCARCINOMA; PANCREATIC DUCTAL ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; UPREGULATION;

14-3-3 PROTEINS; CALCIUM-BINDING PROTEINS; CARCINOMA, PANCREATIC DUCTAL; EXONUCLEASES; FIXATIVES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PARAFFIN EMBEDDING; PROGNOSIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862777470     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3959     Document Type: Article

References (50)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66. (Pubitemid 46148091)
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
4. Kim HN, Choi DW, Lee KT, et al. Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer. Pancreas 2007; 34: 325-334. (Pubitemid 46588258)
5. Nakamura T, Furukawa Y, Nakagawa H, et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004; 23: 2385-2400. (Pubitemid 38496794)
6. Campagna D, Cope L, Lakkur SS, et al. Gene expression profiles associated with advanced pancreatic cancer. Int J Clin Exp Pathol 2008; 1: 32-43.
7. Embuscado EE, Laheru D, Ricci F, et al. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther 2005; 4: 548-554. (Pubitemid 41351229)
8. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-1117.
9. Campbell PJ, Yachida S, Mudie LJ, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010; 467: 1109-1113.
10. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989; 8: 98-101.
11. Cui Y, Wu J, Zong M, et al. Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int J Cancer 2009; 124: 1614-1621.
12. Guo T, Wang W, Rudnick PA, et al. Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens. J Histochem Cytochem 2007; 55: 763-772. (Pubitemid 46981773)
13. Kislinger T, Cox B, Kannan A, et al. Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006; 125: 173-186.
14. Nirmalan NJ, Harnden P, Selby PJ, et al. Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges. Mol Biosyst 2008; 4: 712-720. (Pubitemid 351871751)
15. Scicchitano MS, Dalmas DA, Boyce RW, et al. Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteomic profiles by mass spectrometry. J Histochem Cytochem 2009; 57: 849-860.
16. Sprung RW, Brock JW, Tanksley JP, et al. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol Cell Proteomics 2009; 8: 1988-1998.
17. Reimel BA, Pan S, May DH, et al. Proteomics on fixed tissue specimens - a review. Curr Proteomics 2009; 6: 63-69.
18. Patel V, Hood BL, Molinolo AA, et al. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 2008; 14: 1002-1014. (Pubitemid 351302545)
19. Prieto DA, Hood BL, Darfler MM, et al. Liquid Tissue: proteomic profiling of formalin-fixed tissues. Biotechniques 2005; Suppl: 32-35.
20. Cagney G, Park S, Chung C, et al. Human tissue profiling with multidimensional protein identification technology. J Proteome Res 2005; 4: 1757-1767. (Pubitemid 41464804)
21. Delahunty CM, Yates JR. MudPIT: multidimensional protein identification technology. Biotechniques 2007; 43: 563, 565, 567 passim.
22. Wolters DA, Washburn MP, Yates JR. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 2001; 73: 5683-5690. (Pubitemid 33126725)
23. Froeling FE, Mirza TA, Feakins RM, et al. Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells. Am J Pathol 2009; 175: 636-648.
24. Liu H, Sadygov RG, Yates JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004; 76: 4193-4201. (Pubitemid 38943698)
25. Zhang B, VerBerkmoes NC, Langston MA, et al. Detecting differential and correlated protein expression in label-free shotgun proteomics. J Proteome Res 2006; 5: 2909-2918. (Pubitemid 44749209)
26. Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-168. (Pubitemid 28144151)
27. Whiteman HJ, Weeks ME, Dowen SE, et al. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 2007; 67: 8633-8642. (Pubitemid 47437439)
28. Chelala C, Hahn SA, Whiteman HJ, et al. Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets. BMC Genomics 2007; 8: 439.
29. Chen R, Brentnall TA, Pan S, et al. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics 2007; 6: 1331-1342. (Pubitemid 47365432)
30. Chen R, Pan S, Cooke K, et al. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas 2007; 34: 70-79. (Pubitemid 46045723)
31. Chen R, Yi EC, Donohoe S, et al. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 2005; 129: 1187-1197. (Pubitemid 41446859)
32. Gronborg M, Bunkenborg J, Kristiansen TZ, et al. Comprehensive proteomic analysis of human pancreatic juice. J Proteome Res 2004; 3: 1042-1055. (Pubitemid 39425662)
33. Hu L, Evers S, Lu ZH, et al. Two-dimensional protein database of human pancreas. Electrophoresis 2004; 25: 512-518. (Pubitemid 38263393)
34. Lu Z, Hu L, Evers S, et al. Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue. Proteomics 2004; 4: 3975-3988. (Pubitemid 39657472)
35. Shen J, Person MD, Zhu J, et al. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004; 64: 9018-9026. (Pubitemid 39665512)
36. Weeks ME, Hariharan D, Petronijevic L, et al. Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma. Proteomics Clin Appl 2008; 2: 1047-1057.
37. Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 2005; 4: 1742-1751. (Pubitemid 41464802)
38. Zhang H, Lv L, Liu H, et al. Profiling the potential biomarkers for cell differentiation of pancreatic cancer using iTRAQ and 2-D LC-MS/MS. Proteomics Clin Appl 2009; 3: 862-871.
39. Ghaemmaghami S, Huh WK, Bower K, et al. Global analysis of protein expression in yeast. Nature 2003; 425: 737-741. (Pubitemid 37314318)
40. Okada T, Masuda N, Fukai Y, et al. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas. Anticancer Res 2006; 4B: 3105-3110. (Pubitemid 44161807)
41. Sitek B, Sipos B, Alkatout I, et al. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J Proteome Res 2009; 8: 1647-1656.
42. Zervos EE, Tanner SM, Osborne DA, et al. Differential gene expression in patients genetically predisposed to pancreatic cancer. J Surg Res 2006; 135: 317-322. (Pubitemid 44414883)
43. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63: 2649-2657. (Pubitemid 36605209)
44. Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009; 19: 16-23.
45. Arumugam T, Ramachandran V, Logsdon CD. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 2006; 98: 1806-1818. (Pubitemid 46017932)
46. Arumugam T, Simeone DM, Schmidt AM, et al. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 2004; 279: 5059-5065. (Pubitemid 38220521)
47. Arumugam T, Simeone DM, Van Golen K, et al. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005; 11: 5356-5364. (Pubitemid 41060808)
48. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003; 201: 63-74. (Pubitemid 37121204)
49. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 2005; 166: 81-92. (Pubitemid 40051662)
50. Heil A, Nazmi AR, Koltzscher M, et al. S100P is a novel interaction partner and regulator of IQGAP1. J Biol Chem 2011; 286: 7227-7238.